Dysesthesia is the signal that has drawn most clinical attention, because it does not feature in the semaglutide or tirzepatide profiles
Always consult a qualified clinician before starting treatment
Semaglutide was recently approved as a treatment for the prevention of heart attacks, and preliminary studies suggest that tirzepatide also imparts broad cardiovascular benefits
This product is a synchronized combination of three distinct synthetic peptides designed to study growth hormone (GH) release pathways
If you suspect you've experienced a side effect from either medication, report it through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Antioxid Redox Signal 28(8):643661 Thilagavathi R, Begum SS, Varatharaj SD, Balasubramaniam Ak, George JS, Selvam C (2023) Recent insights into the hepatoprotective potential of medicinal plants and plant-derived compounds